PT4070800T - Regime de cladribina para o tratamento de esclerose múltipla - Google Patents

Regime de cladribina para o tratamento de esclerose múltipla

Info

Publication number
PT4070800T
PT4070800T PT221666100T PT22166610T PT4070800T PT 4070800 T PT4070800 T PT 4070800T PT 221666100 T PT221666100 T PT 221666100T PT 22166610 T PT22166610 T PT 22166610T PT 4070800 T PT4070800 T PT 4070800T
Authority
PT
Portugal
Prior art keywords
multiple sclerosis
treating multiple
cladribine
regimen
cladribine regimen
Prior art date
Application number
PT221666100T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34930135&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT4070800(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of PT4070800T publication Critical patent/PT4070800T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Pressure Welding/Diffusion-Bonding (AREA)
PT221666100T 2004-12-22 2005-12-20 Regime de cladribina para o tratamento de esclerose múltipla PT4070800T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04106909 2004-12-22

Publications (1)

Publication Number Publication Date
PT4070800T true PT4070800T (pt) 2024-12-30

Family

ID=34930135

Family Applications (4)

Application Number Title Priority Date Filing Date
PT221666100T PT4070800T (pt) 2004-12-22 2005-12-20 Regime de cladribina para o tratamento de esclerose múltipla
PT140019704T PT2805723T (pt) 2004-12-22 2005-12-20 Regime de cladribina para o tratamento de esclerose múltipla
PT05823474T PT1827461E (pt) 2004-12-22 2005-12-20 Regime posológico de cladribina para o tratamento de esclerose múltipla
PT181516345T PT3332789T (pt) 2004-12-22 2005-12-20 Regime de cladribina para o tratamento de esclerose múltipla

Family Applications After (3)

Application Number Title Priority Date Filing Date
PT140019704T PT2805723T (pt) 2004-12-22 2005-12-20 Regime de cladribina para o tratamento de esclerose múltipla
PT05823474T PT1827461E (pt) 2004-12-22 2005-12-20 Regime posológico de cladribina para o tratamento de esclerose múltipla
PT181516345T PT3332789T (pt) 2004-12-22 2005-12-20 Regime de cladribina para o tratamento de esclerose múltipla

Country Status (11)

Country Link
AT (1) ATE547106T1 (sr)
CY (1) CY1125491T1 (sr)
DK (1) DK1827461T3 (sr)
ES (4) ES2382554T3 (sr)
HU (1) HUE035859T2 (sr)
LT (1) LT2805723T (sr)
ME (1) ME01333B (sr)
PT (4) PT4070800T (sr)
RS (1) RS52219B (sr)
SI (1) SI1827461T1 (sr)
UA (1) UA96260C2 (sr)

Also Published As

Publication number Publication date
ME01333B (me) 2013-12-20
HUE035859T2 (en) 2018-05-28
RS52219B (sr) 2012-10-31
PT2805723T (pt) 2018-01-25
CY1125491T1 (el) 2025-05-09
ATE547106T1 (de) 2012-03-15
SI1827461T1 (sl) 2012-05-31
PT3332789T (pt) 2022-07-05
UA96260C2 (ru) 2011-10-25
ES2495392T3 (es) 2014-09-17
ES2666146T3 (es) 2018-05-03
LT2805723T (lt) 2018-02-12
PT1827461E (pt) 2012-05-07
ES2428741T3 (es) 2013-11-11
DK1827461T3 (da) 2012-03-26
ES2382554T3 (es) 2012-06-11

Similar Documents

Publication Publication Date Title
HUS1800009I1 (hu) Kladribin adagolási elõírás szklerózis multiplex kezelésére
ZA200808852B (en) Cladribine regimen for treating multiple sclerosis
IL179139A0 (en) Method for treating multiple sclerosis
IL183900A0 (en) Polymerization processes
EP1773679A4 (en) PACKAGING
GB0418046D0 (en) Eantioselective process
ZA200800123B (en) Method for diagnosing multiple sclerosis
ZAA200501234S (en) Packages
GB0421928D0 (en) Process
EP1827491A4 (en) TREATMENT OF MULTIPLE SCLEROSIS
EP1812665A4 (en) MACHINE FOR HEAVY-HEAD EXTRACTION FOR CUTTED SURFACES
IL180446A0 (en) Object process graph application controller-viewer
TWI367216B (en) Process for stopping continuous polymerization
HU0400305D0 (en) Set for spine-fixture
GB0414335D0 (en) Process
PT4070800T (pt) Regime de cladribina para o tratamento de esclerose múltipla
ZA200704868B (en) Cladrlbine regimen for treating multiple sclerosis
GB2411101B (en) Glove
GB0420561D0 (en) Process
GB0413084D0 (en) Process
GB0424002D0 (en) Process
GB0401540D0 (en) Process
GB0614058D0 (en) Treatment for multiple sclerosis
AU156686S (en) Tunic
AU157092S (en) Tunic